Device Firms Advised To Prepare For Hurdles Under China's RoHS2
Executive Summary
Revised rules introduced by the Chinese government on limiting the use of hazardous substances in electrical and electronic products has implications for medtech companies – both in the short term, such as updating their product's user manual with accurate data, and in the long term, such as replacing product parts to ensure compliance.
You may also be interested in...
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.